Purchase Order 75N91025P00452
Award Date
9/15/25
Potential Completion Date
3/14/26
Potential Value
$113K
Federal Agency
National Cancer Institute
Awardee
Creative Biolabs Inc.
Ultimate Awardee
Not listed
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
East Yaphank, NY 11967, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $19,980.00 firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health, National Cancer Institute to Creative Biolabs Inc. for laboratory testing services. The contract has a period of performance from May 15, 2024 to July 10, 2024 and does not have a set-aside designation. Creative Biolabs Inc. is a for-profit organization that specializes in providing custom biotechnology and pharmaceutical services to support federal...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a component of the National Institutes of Health (NIH), to Creative Biolabs Inc., a for-profit biotechnology and pharmaceutical services company. The $9,980.00 contract is for lab testing services and does not have a set-aside designation. Creative Biolabs has a history of securing federal contracts from various civilian agencies, including the NIH and its specialized institutes, to provide advanced...
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $21,657 purchase order to Genscript USA Inc. to produce eight BM306 protein constructs. The firm fixed price contract has a period of performance from July 17, 2023 through September 1, 2023 and will be performed in Piscataway, New Jersey. The NCI supports basic and clinical cancer research across its various centers and divisions to better understand, diagnose, and treat...
This federal contract was awarded by the Department of Health and Human Services, National Institutes of Health, National Cancer Institute to The New York Structural Biology Center, Inc., a non-profit organization, to provide services generating high resolution X-ray crystal structures of the extracellular domains of chimeric antigen receptor (CAR) proteins and other immunologically relevant surface receptors and co-receptors, as well as their interactions with tumor antigens. The contract is...
This is a firm fixed-price purchase order contract awarded by the Office of Naval Research, a defense agency, to Creative Biomart Inc. (doing business as Creative Enzymes), a for-profit small disadvantaged business. The $25,835 contract is for Creative Biomart to produce large M13 phage pellets harvested from a 20 L bacterial cell culture. The contract has an ultimate completion date of October 4, 2024. No set-aside designation is noted. Creative Biomart has previously performed contracts with...
The National Institutes of Health's National Cancer Institute awarded a $101,200 firm fixed price delivery order contract to Medical Science & Computing, LLC. The contract is to provide antibody sequencing services to incorporate into chimeric antigen receptor T-cells under Solicitation 241. The work will be performed in Ottawa, Ontario, Canada from July 2023 through July 2024. This delivery order was awarded against an unidentified NIH master agreement vehicle and will support the...
This is a firm-fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to the prime contractor Aldevron, L.L.C., a for-profit limited liability company that manufactures biologics. The contract is for the production and purification of custom DNA plasmids, specifically 600 mg of pM766 gp160 V1, 40 mg of pSW M766 gp120 V1, and 600 mg of SIV p57 Gag custom plasmids, to support ongoing research...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $210,338.00 firm fixed-price purchase order to Creative Biolabs Inc. for mouse antibody production services across Phases I through IV. The contract, which runs through September 22, 2025, does not have a set-aside designation. Creative Biolabs, a specialized biotechnology and pharmaceutical services provider, will deliver custom solutions in...
This is a delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) to Medical Science & Computing, LLC, a for-profit limited liability company. The contract is for CGMP (current good manufacturing practice) plasmid production services to support the National Cancer Institute (NCI). The total potential value of the contract is $275,000.00, and it is a firm-fixed-price contract with a completion date of May 31, 2022. The contract was...
This is a firm fixed price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Lentigen Technology, Inc. for the manufacture of a good manufacturing practice (GMP) lot of a lentiviral vector encoding a CD19/CD22 targeting bispecific chimeric antigen receptor (CD19/CD22 BiCAR) gene for clinical use. The contract has a ceiling value of $322,000.00 and a completion date of August 7, 2017. The contract was awarded on August 8, 2016 and was not set aside...